Business Wire

Cegid Closes Acquisition of Shine to Create Europe's First Complete AI-Driven Platform for SMBs and Accountants

8.6.2026 09:28:00 CEST | Business Wire | Press Release

Share

Cegid, a European leader in cloud management solutions for professionals in the finance (treasury, tax, ERP), human resources (payroll, talent management), accountancy, retail and entrepreneurship sectors, today announced the completion of its acquisition of Shine. The transaction creates the first fully integrated, cloud-native and AI-driven financial hub for SMBs and accounting professionals in Europe.

Shine – a fast-growing European fintech unicorn providing electronic invoicing, accounting, business accounts, and payroll software to small and medium-sized businesses across Europe – brings more than 400,000 SMB customers, a strong brand, and a scalable technology stack, expanding Cegid’s reach in key European markets. The consolidated group will serve more than one million SMBs and 15,000 accountants across France, Germany, Spain, Portugal, Denmark, the Netherlands and Belgium.

Shine’s combination with Cegid and its full ecosystem represents the formation of Europe’s first 100% cloud-based financial platform, equipped with native AI and designed end-to-end for SMBs and accounting firms. Built on Cegid’s leadership in cloud and AI, this unique, fully compliant and connected platform brings together leading capabilities in e-invoicing, accounting, payment solutions, payment cards and associated business accounts, tax, HR, payroll and reporting. These capabilities position SMBs and accountants for Europe’s mandatory e-invoicing and digital reporting reforms while helping accounting firms reduce operational complexity and increase productivity to allow them to focus on what matters most: delivering higher value-added services to customers and growing their business.

The new combined unit within Cegid dedicated to the SMB market and accounting firms, comprising 2,300 employees, will be led by Rico Adlor-Andersen, co-founder of Shine.

“From the creation of Shine to its growth into a leading European unicorn, our mission has always been the same: to radically eliminate complexity for entrepreneurs. With Cegid, that mission takes on a whole new dimension. Today, we are bringing two category leaders together to create Europe's first truly unified financial hub, serving millions of SMBs and their accountants. This is a decisive milestone in the achievement of our vision and the beginning of a new ambition at a European scale,” comments Rico Adlor-Andersen, co-founder of Shine.

"The completion of this combination is a landmark moment for Cegid and for the millions of small businesses and accountants we serve across Europe. By uniting Cegid's cloud and AI leadership with Shine's innovative digital finance platform, we have created a truly unique offering, Europe's first unified financial hub built to simplify the lives of entrepreneurs and empower the accounting profession. As mandatory e-invoicing and digital reporting reshape the European landscape, this platform positions our customers to turn regulatory change into a growth opportunity. Cegid is a business of exceptional quality, and that quality is what makes a transaction like this possible in an environment where financing markets for software companies have been sluggish. Silver Lake’s role is to back great companies with conviction and the resources to grow, and we are proud to do exactly that here in partnership with the Cegid and Shine teams as they continue building one of Europe's defining technology companies," comments Christian Lucas, Chairman of Cegid and Managing Partner at Silver Lake.

“This acquisition complements our portfolio and reinforces our commitment to serving businesses of all sizes, enabling them to be more agile in their financial and HR management. For the SMB and accountant services market, the integration of Shine marks a decisive step in Cegid’s ambition to become Europe's leading financial copilot for SMBs and accountants. Now more than ever, we are reaffirming our mission and our unwavering commitment—established over 40 years ago—to accountants and businesses. Cegid will help them take advantage of the huge opportunities offered by the digital transformation of the coming decade,” concludes Bruno Vaffier, Cegid General Manager.

The transaction was financed through Cegid’s operating cash generation and a new €1.1 billion financing facility provided by leading direct credit funds, following an innovative two-step financing process with prior underwriting by Citibank, J.P. Morgan, RBC Capital Markets, and UBS. This represents one of the most significant software financings completed in the European market in recent months, executed via a structure that reflects both the strength of Cegid’s business fundamentals and the depth of its relationships across the global credit investor community.

About Shine

Founded by serial entrepreneurs Rico Adlor-Andersen and Martin Hegelund, Shine's vision is to restore the joy of running a business, by ending wasted time on financial admin. Shine offers a ‘financial copilot’ by integrating its solutions into a single platform for invoicing, accounting, payroll, business accounts and payments, and financing. Shine is a leading European fintech unicorn, operating across France, Denmark, the Netherlands, and Germany, serving over 400,000 customers. Shine France is regulated as a payment institution by the Autorité de contrôle prudentiel et de résolution (ACPR) and was recognised as “Best Business Bank” by ESCDA in 2024, 2025, and 2026.

About Cegid

Cegid is a European leader in cloud management solutions for professionals in the Finance (treasury, tax, ERP), Human Resources (payroll, talent management), Accounting, Retail and entrepreneurship sectors. With a solid full-cloud business model, Cegid is committed to the long term with its customers and supports the digitalization of companies, from small businesses to large accounts, for a superior, distinctive and memorable experience in France and abroad. Cegid combines a forward-looking and pragmatic vision of the business, a strong capacity for innovation, mastery of new technologies such as artificial intelligence and a unique knowledge of regulations. In a rapidly changing world, Cegid opens up possibilities and reveals the full value of its customers’ businesses by providing useful and innovative solutions.

With its international ambitions and more than one million customers, Cegid now has more than 5,000 employees and sells its solutions in 130 countries. Cegid generated annual revenue of €1,069 million (as of December 31, 2025).

More information: www.cegid.com

View source version on businesswire.com: https://www.businesswire.com/news/home/20260607209706/en/

Contacts

PR contacts:
Shine – agence Hodos
Charlotte Lance
c.lance@hodos.paris
+33 (0)6 42 44 22 90

Shine – agence Hodos
Gratiane Sametin
g.sametin@hodos.paris
+33 (0)7 85 92 60 78

Cegid - Responsable Relations Presse
Nathalie Fournier-Christol
nfournierchristol@cegid.com
+33 (0)6 49 23 83 14

(c) 2024 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Shilpa Medicare and Gate2Brain Sign Strategic Equity Partnership to Advance First-in-Class Brain Cancer Therapy8.6.2026 12:00:00 CEST | Press Release

Shilpa Biocare Pvt Ltd, a Subsidiary of Shilpa Medicare Limited (BSE/NSE: SHILPAMED) has entered a strategic equity partnership with Gate2Brain, S.L., a biotechnology company focused on CNS therapeutics. Shilpa becomes a strategic shareholder and CMC, manufacturing, and regulatory partner for G2B-002 — Gate2Brain's lead program targeting deadly pediatric brain cancers, DIPG and pGBM, both with Orphan Drug Designation from the US FDA and EMA. G2B-002 uses Gate2Brain's proprietary MiniAp4 peptide shuttle to deliver SN-38 across the blood-brain barrier, demonstrating up to 100-fold greater brain drug transport preclinically. First-in-human trials are anticipated by FY28. G2B-002 targets high-growth oncology markets — the glioblastoma market projected at USD 6.48B by 2035 (CAGR: 7.97%), pediatric brain tumors at USD 2.47B by 2031 (CAGR: 6.9%), and DIPG at USD 1.2B by 2035 (CAGR: 7.1%). Gate2Brain's MiniAp4 platform further extends potential across rare pediatric cancers and broader CNS cat

Haleon Invests in India to Deliver Better Everyday Health to Rural Communities8.6.2026 11:11:00 CEST | Press Release

Haleon, a consumer company that is solely focused on better everyday health, today announces plans to expand its business in India, one of its fastest-growing markets and key to Haleon delivering its strategy and ambitions to reach one billion more consumers by 2030. Haleon will invest approximately £175 million2 in building a new oral health manufacturing site in Madhya Pradesh, central India and accelerate distribution efforts in rural India to meet rising demand. The new site will also support supply for wider Asia. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260608753094/en/ Haleon Health Ambassador on motorbike, equipped with testing kits, samples and diagnostic tools Building capacity to meet rising demand The new site, which is well-positioned in the middle of the country and close to some of India’s most renowned technical colleges, marks an important step in the delivery of Haleon’s Win as One strategy. Win as On

Diabetology’s Breakthrough Clinical Data From Oraglutide™ Oral GLP-18.6.2026 10:56:00 CEST | Press Release

Diabetology Limited (Jersey) poster presentation (https://diabetology.co.uk/ada-poster) 1724-P at the ADA 86th Scientific Session, New Orleans, reporting first human data from Oraglutide™ — small capsule intestinally-released oral semaglutide, formulated using the proprietary Axcess™ delivery technology. KEY HIGHLIGHTS 6-day glucose control: A single 4 mg oral dose of Oraglutide™ produced a sustained fall in glucose. Measuring 14% at Day 6 (p=.046), the longest duration presented from a single oral GLP-1 dose in a human IVGTT study. 28% increase in insulin secretion: Relative to placebo, insulin percent AUC increased by 12% day 0, (p=0.02) & 28% Day 1 (p = 0.025). Novel intestinal depot effect: Blood levels of semaglutide were higher on Day 1 than dosing on Day 0, consistent with lipid associated depot effect in the intestinal wall, a fundamentally new pharmacological finding. No nausea or side effects observed: No adverse events observed across the 8-subject cohort over one week, cons

Reply at VivaTech 2026: Making AI, Agents and Robotics Happen Across the Enterprise8.6.2026 10:00:00 CEST | Press Release

Reply[EXM, STAR: REY] is taking part in VivaTech 2026, Europe's largest innovation and technology event, held from June 17 to 20 at Paris Expo Porte de Versailles. At the event, Reply will showcase its latest innovations around AI for software engineering, AI-powered experiences, data and AI, and industrial AI. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260608667672/en/ At VivaTech 2026 Reply will showcase its latest innovations around AI for software engineering, AI-powered experiences, data and AI, and industrial AI. Industries are being reshaped by AI, autonomous agents, robotics and new digital experiences. From strategy to execution, Reply helps companies move beyond experimentation and innovative ideas into concrete business value. Visitors can meet Reply in Hall 7.1, booth 1G12, and explore how, through real use cases, scalable solutions and live demonstrations, the group makes innovation happen. This year, Reply'

Cardiolife Partners with Bhutan Ministry of Health to Strengthen Nationwide Cardiac Care8.6.2026 10:00:00 CEST | Press Release

Cardiolife is proud to partner with the Ministry of Health of Bhutan to roll out its advanced AI-powered ECG diagnostics system nationwide. The collaboration will provide access to early ECG diagnosis and prevention, marking a major step forward in the country’s effort to strengthen heart health and preventive care. Bhutan has a population of just over 700,000 people and heart failure and other cardiac conditionsare among the leading causes of death. Following constructive meetings in Thimphu, His Excellency, the Health Minister, officially endorsed the national rollout of Cardiolife’s solution and expressed appreciation for Cardiolife’s commitment to advancing cardiac care through the provision of free software and ECG equipment in Bhutan. “We are grateful to the Cardiolife team for their commitment to improving heart health in Bhutan. With cardiovascular diseases on the rise, this collaboration marks an important milestone in our journey to strengthen early detection and prevention a

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye